Intelligence Platform
Patents
Browse 222 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10793855
Compositions for modulating expression of C9ORF72 antisense transcript
granted patentUS 10793862
Compositions and methods for modulating growth hormone receptor expression
granted patentUS 10774333
Modulators of PNPLA3 expression
granted patentUS 10772906
Modulation of Factor 11 expression
granted patentUS 10751419
Method for synthesis of reactive conjugate clusters
granted patentUS 10683499
Compositions and methods for modulating TTR expression
granted patentUS 10655129
Compositions and their uses directed to huntingtin
granted patentUS 10619157
Cancer treatment
granted patentUS 10619158
Modulation of huntingtin expression
granted patentUS 10577607
Modulation of DYRK1B expression
granted patentUS 10577604
Methods for monitoring C9ORF72 expression
granted patentUS 10570169
Conjugated antisense compounds and their use
granted patentUS 10557137
Modulating apolipoprotein (a) expression
granted patentUS 10538763
Compounds and methods for modulation of DUX4
granted patentUS 10533175
Compositions and methods for modulating Ataxin 3 expression
granted patentUS 10526604
Modulation of nuclear-retained RNA
granted patentUS 10517889
Modulators of SMAD7 expression
granted patentUS 10517953
Modulators of PCSK9 expression
granted patentUS 10493092
Antisense compounds
granted patentUS 10478448
Methods and compositions for modulating apolipoprotein (a) expression
granted patentUS 10479993
Modulation of signal transducer and activator of transcription 3 (STAT3) expression
granted patentUS 10478449
2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations
granted patentUS 10472629
Methods and compositions for modlating apolipoprotein (A) expression
granted patentUS 10443052
Compositions for modulating C9ORF72 expression
granted